Production (Stage)
Silence Therapeutics plc
SLN
$5.94
$0.7514.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.23% | 114.18% | 140.89% | 196.23% | 148.06% |
| Total Receivables | -29.20% | 12.22% | 4.12% | -42.90% | 54.67% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 26.37% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 28.09% | -- | 16.04% | 79.81% | 23.57% |
| Total Current Assets | -26.03% | 81.64% | 97.48% | 113.09% | 121.71% |
|
|
|||||
| Total Current Assets | -26.03% | 81.64% | 97.48% | 113.09% | 121.71% |
| Net Property, Plant & Equipment | -20.42% | -14.43% | -6.12% | -17.73% | -12.97% |
| Long-term Investments | 0.20% | -5.90% | 5.67% | -1.97% | -0.87% |
| Goodwill | 0.20% | -5.90% | 5.67% | -1.97% | -0.87% |
| Total Other Intangibles | -10.74% | -13.81% | -3.30% | -12.09% | -9.44% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.56% | -1.54% | -- | -- | -- |
| Total Assets | -24.52% | 69.64% | 89.95% | 102.35% | 110.35% |
|
|
|||||
| Total Accounts Payable | 42.03% | 10.42% | 31.22% | 22.24% | -19.18% |
| Total Accrued Expenses | -- | 2.86% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -74.18% | -48.68% | -24.05% | -7.59% | 4.36% |
| Total Finance Division Other Current Liabilities | -91.14% | -86.40% | -53.17% | -61.59% | -17.52% |
| Total Other Current Liabilities | -91.14% | -86.40% | -53.17% | -61.59% | -17.52% |
| Total Current Liabilities | 7.60% | -24.69% | 3.10% | -8.76% | -18.53% |
|
|
|||||
| Total Current Liabilities | 7.60% | -24.69% | 3.10% | -8.76% | -18.53% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -56.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -24.93% | -30.95% | 6.42% | -4.72% | -3.99% |
| Total Liabilities | -18.49% | -29.60% | 5.50% | -5.90% | -7.46% |
|
|
|||||
| Common Stock & APIC | 35.99% | 33.41% | 64.20% | 53.77% | 59.63% |
| Retained Earnings | -32.25% | -9.76% | -31.01% | -12.60% | -14.57% |
| Treasury Stock & Other | -- | -- | 23.87% | 14.59% | 19.64% |
| Total Common Equity | -27.95% | 509.39% | 419.09% | 812.92% | 662.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.95% | 509.39% | 419.09% | 812.92% | 662.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.95% | 509.39% | 419.09% | 812.92% | 662.45% |
|
|
|||||